M12.28
Villonodular synovitis (pigmented), other specified site
Clinical Classification Guidelines
Inclusion Terms
- Villonodular synovitis (pigmented), vertebrae
Medical Intelligence & Overview
Pigmented villonodular synovitis (PVNS) is a rare, non-cancerous condition characterized by the abnormal growth of the synovial membrane, which lines joints, bursae, and tendon sheaths. When this proliferation occurs in the vertebrae, it causes specific symptoms and challenges. This form of PVNS is classified under ICD-10 code M12.28, highlighting its identification at a particular site within the axial skeleton.
Causes & Symptoms
Clinical Causes: Exact cause of PVNS, including in the vertebrae, remains unknown but is believed to involve abnormal proliferation of synovial tissue. Possible genetic or inflammatory factors may contribute, though research is ongoing. Trauma or joint injury has not been definitively linked but might play a role in some cases.
Key Symptoms: Localized pain in the affected area of the spine. Swelling or a palpable mass near the affected vertebrae. Limited range of motion or stiffness in the back or neck. In some cases, nerve compression symptoms such as numbness, tingling, or weakness may occur if the growth impinges on nerve structures. Persistent discomfort that worsens with activity.
Diagnostic & Treatment
Diagnosis Path: Medical history assessment focusing on symptom duration and severity. Physical examination to identify tenderness, swelling, or neurological signs. Imaging tests such as MRI are crucial for visualization of the abnormal synovial tissue, often showing characteristic pigmented nodular growths. Biopsy may be performed to confirm diagnosis and rule out other conditions like tumors or infections. Additional imaging like CT scans can help assess the extent of bone involvement.
Treatment Protocols: Surgical removal of the proliferative synovial tissue is typically the primary treatment. Complete excision reduces the chance of recurrence, especially important given the potential for local tissue invasion. In some cases, radiation therapy may be considered to address residual disease or recurrence risks. Adjunct therapies, including anti-inflammatory medications, are used to manage symptoms but do not treat the underlying condition. Rehabilitation and physical therapy may be necessary post-treatment to restore function and mobility.
Clinical Advice & FAQs
Billing Guidance
Is M12.28 a billable ICD-10 code?
Yes, M12.28 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M12.28?
Clinical documentation must specify the nature of Villonodular synovitis (pigmented), other specified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference